NCT02813850View on ClinicalTrials.gov

Oxygen Therapy and Pregnancy in Sickle Cell Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

October 5, 2016

Primary Completion Date

December 3, 2021

Study Completion Date

August 12, 2022

Conditions
Sickle Cell Disease
Interventions
DEVICE

oxygen therapy

Oxygen therapy early in the night (2L/min) during 4hours per days

Trial Locations (1)

75015

Hôpital Necker Enfants-Malades (Public Hospitals of Paris), Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02813850 - Oxygen Therapy and Pregnancy in Sickle Cell Disease | Biotech Hunter | Biotech Hunter